Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.
27 result(s)
26/03/2020
15:25
bytes
Présentation analystes & investisseurs - 26 mars 2020
26/03/2020
08:00
2.02 MB
21/03/2019
08:00
3.23 MB
22/03/2018
18:56
bytes

Présentation analystes & investisseurs - 15 mars 2018

15/03/2018
14:00
2.87 MB

Investors and Analysts - March 15, 2018

28/03/2017
17:41
2.88 MB

Vétoquinol - 23.03.2017 - 18h15 - Enregistrement Audio Conference

23/03/2017
08:06
2.88 MB

Présentation analystes & investisseurs - 23 mars 2017

22/03/2016
10:38
1.04 MB

2015 Annual Results

24/03/2015
09:30
1.15 MB
Sustained growth, Reference products drive growth in 2014.
2014 key figures.
18/03/2014
16:00
2.74 MB
SFAF meeting March 13, 2014
17/05/2013
17:45
2.26 MB
Founded in 1933, Vétoquinol is now a leading global animal health company. The number 10 global animal health company and the third largest in France, the Vétoquinol Group combines sustainability, growth and independence in an increasingly competitive world market. Committed to the protection and well-being of both animals and people, Vétoquinol creates, develops and sells veterinary drugs and non-medical products all over the world. The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats). For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.
30/04/2013
17:00
986.35 KB
1.1CONSOLIDATED FINANCIAL STATEMENTS p.4
28/03/2013
12:00
2.18 MB
SFAF Meeting March 27, 2013
12/04/2012
23:53
2.72 MB

Our business: animals. Our advantage: people.

05/04/2012
23:00
2.69 MB
SFAF meeting April 4, 2012
27/04/2011
17:00
2.44 MB
P_06 VÉTOQUINOL’S PROUD HISTORY
P_12 SPOTLIGHT ON INNOVATION
P_18 AN ONGOING DAILY COMMITMENT TO VETERINARIANS
P_24 AN INTERNATIONAL COMPANY MAINTAINING A LOCAL PRESENCE IN GLOBAL MARKETS
P_28 GOVERNANCE AND KEY FIGURES
12/04/2011
16:00
1 MB
Contents :
> Highlights
> 2010 Consolidated Financial Statements
> Strategy and Outlook
> Questions and Answers
21/04/2010
15:00
2.84 MB

p.01 PROFIL / CHIFFRES CLÉS
Une marque d’indépendance

p.02 LE MOT DE LA DIRECTION
Une progression remarquable

p.04 LA GRANDE HISTOIRE DE VÉTOQUINOL
11e laboratoire pharmaceutique vétérinaire

p.08 CLIENTS VÉTÉRINAIRES
Entre vétérinaires, on se comprend

p.12 RECHERCHE & DÉVELOPPEMENT
Toujours une innovation d’avance

p.14 ANIMAUX DE RENTE ET DE COMPAGNIE
Questions de tailles, réponses de poids

p.16 L’OUTIL INDUSTRIEL
Un modèle de performance industrielle

p.18 MARKETING
Plus que des boîtes, de la valeur ajoutée

p.22 INTERNATIONAL
Spécial Inde, en route vers l’Asie

p.26 CARNET DE L’ACTIONNAIRE
Une dynamique de croissance et de performance
p.01 PROFILE/KEY FIGURES
An Independent Brand

p.02 A WORD FROM MANAGEMENT
Remarkable Growth

p.04 COMPANY BACKGROUND
Vétoquinol’s Proud History

p.08 VET CLIENTS
Seeing Eye-to-Eye with Veterinarians

p.12 RESEARCH AND DEVELOPMENT
Always at the Forefront of Innovation

p.14 LIVESTOCK AND COMPANION ANIMALS
Sizeable Issues Call for Proportionate Answers

p.16 PRODUCTION FACILITIES
A Model of Industrial Performance

p.18 MARKETING
More than just Packaging, Adding Value

p.22 INTERNATIONAL MARKETS
Spotlight on India, on the Way to Asia

p.26 REPORT TO SHAREHOLDERS
Growth and Performance Momentum
01/04/2010
12:00
5.05 MB
Sommaire
- Highlights
- 2009 consolidated financial statements
- Strategy and outlook
- Questions and answers
01/09/2009
18:30
254.41 KB
Le chiffre d’affaires de Vétoquinol pour le 1er semestre 2009 s’établit à 119,9 M€, en croissance de 2,7% par rapport au premier semestre de l’exercice précédent.
Basket
Empty basket

INVESTORS CORNER

Vetoquinol has been listed on the Euronext Paris stock market since November 16th.

Consult the documents of the Meeting

Contact

Composition of the bodies of Corporate Management and Governance

Financial information and key figures: annual, half-year and by sector key figures